Fig. 6From: Dynamic modulations of urinary sphingolipid and glycerophospholipid levels in COVID-19 and correlations with COVID-19-associated kidney injuriesScheme showing the modulation of urinary sphingolipids and glycerophospholipids in COVID-19. The scheme summarizes the general dynamic modulations of sphingolipids and glycerophospholipids in COVID-19Back to article page